These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24719556)

  • 1. Reactive oxygen species are involved in regulating hypocontractility of mesenteric artery to norepinephrine in cirrhotic rats with portal hypertension.
    Chen W; Liu DJ; Huo YM; Wu ZY; Sun YW
    Int J Biol Sci; 2014; 10(4):386-95. PubMed ID: 24719556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitization of G-protein-coupled receptors induces vascular hypocontractility in response to norepinephrine in the mesenteric arteries of cirrhotic patients and rats.
    Chen W; Sang JY; Liu DJ; Qin J; Huo YM; Xu J; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):295-304. PubMed ID: 23742775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular dysfunction in human and rat cirrhosis: role of receptor-desensitizing and calcium-sensitizing proteins.
    Hennenberg M; Trebicka J; Biecker E; Schepke M; Sauerbruch T; Heller J
    Hepatology; 2007 Feb; 45(2):495-506. PubMed ID: 17256744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DPP4 inhibitor reduces portal hypertension in cirrhotic rats by normalizing arterial hypocontractility.
    Wang X; Gu H; Li K; Lin J; Zhu Y; Deng W
    Life Sci; 2021 Nov; 284():119895. PubMed ID: 34450166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen improves the hyperdynamic circulation and hyporeactivity of mesenteric arteries by alleviating oxidative stress in partial portal vein ligated rats.
    Zhang B; Zhang CG; Zhou QB; Chen W; Wu ZY
    World J Gastroenterol; 2013 Oct; 19(40):6863-8. PubMed ID: 24187462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats.
    Hennenberg M; Biecker E; Trebicka J; Jochem K; Zhou Q; Schmidt M; Jakobs KH; Sauerbruch T; Heller J
    Gastroenterology; 2006 Mar; 130(3):838-54. PubMed ID: 16530523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of vasoactive proteins in gastric antral mucosa reflects vascular dysfunction in patients with cirrhosis and portal hypertension.
    Trebicka J; Wix C; von Heydebrand M; Hittatiya K; Reiberger T; Klein S; Schierwagen R; Kristiansen G; Peck-Radosavljevic M; Fischer HP; Møller S; Bendtsen F; Krag A; Sauerbruch T
    Liver Int; 2015 Apr; 35(4):1393-402. PubMed ID: 24912856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
    Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
    Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of estrogen receptor β selective agonist in ameliorating portal hypertension in rats with CCl4-induced liver cirrhosis.
    Zhang CG; Zhang B; Deng WS; Duan M; Chen W; Wu ZY
    World J Gastroenterol; 2016 May; 22(18):4484-500. PubMed ID: 27182159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased endothelin receptor B and G protein coupled kinase-2 in the mesentery of portal hypertensive rats.
    Du QH; Han L; Jiang JJ; Li PT; Wang XY; Jia X
    World J Gastroenterol; 2013 Apr; 19(13):2065-72. PubMed ID: 23599626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NADPH oxidase 1/4 inhibition attenuates the portal hypertensive syndrome via modulation of mesenteric angiogenesis and arterial hyporeactivity in rats.
    Deng W; Duan M; Qian B; Zhu Y; Lin J; Zheng L; Zhang C; Qi X; Luo M
    Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):255-265. PubMed ID: 30413372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats.
    Trebicka J; Leifeld L; Hennenberg M; Biecker E; Eckhardt A; Fischer N; Pröbsting AS; Clemens C; Lammert F; Sauerbruch T; Heller J
    Hepatology; 2008 Apr; 47(4):1264-76. PubMed ID: 18318439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in vascular reactivity of mesenteric arterioles in portal hypertensive and non-portal hypertensive rats.
    Zhang B; Ji LH; Zhang CG; Zhao G; Wu ZY
    World J Gastroenterol; 2019 Oct; 25(39):5953-5960. PubMed ID: 31660032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and functional implication of a Rho kinase-dependent moesin-EBP50 interaction in noradrenaline-stimulated artery.
    Baeyens N; Horman S; Vertommen D; Rider M; Morel N
    Am J Physiol Cell Physiol; 2010 Dec; 299(6):C1530-40. PubMed ID: 20926777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis.
    Zhou Q; Hennenberg M; Trebicka J; Jochem K; Leifeld L; Biecker E; Sauerbruch T; Heller J
    Gut; 2006 Sep; 55(9):1296-305. PubMed ID: 16492715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased PDZ-RhoGEF/RhoA/Rho kinase signaling in small mesenteric arteries of angiotensin II-induced hypertensive rats.
    Hilgers RH; Todd J; Webb RC
    J Hypertens; 2007 Aug; 25(8):1687-97. PubMed ID: 17620967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of miR-26b on hepatic cirrhosis and portal pressure in rats with cirrhotic portal hypertension by targeting hENT1 depending on RhoA/ROCK-1 pathway.
    Chen Y; Tian Y
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1668-1673. PubMed ID: 30840291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rho-kinase inhibitor coupled to peptide-modified albumin carrier reduces portal pressure and increases renal perfusion in cirrhotic rats.
    Klein S; Frohn F; Magdaleno F; Reker-Smit C; Schierwagen R; Schierwagen I; Uschner FE; van Dijk F; Fürst DO; Djudjaj S; Boor P; Poelstra K; Beljaars L; Trebicka J
    Sci Rep; 2019 Feb; 9(1):2256. PubMed ID: 30783172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired agonist-dependent myosin phosphorylation and decreased RhoA in rat portal hypertensive mesenteric vasculature.
    Zhang HY; Shirasawa Y; Chen X; Yu H; Benoit JN
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G603-8. PubMed ID: 15513955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome analysis of mesenteric arterioles changes and its mechanisms in cirrhotic rats with portal hypertension.
    Wu G; Chen M; Fan Q; Li H; Zhao Z; Zhang C; Luo M
    BMC Genomics; 2023 Jan; 24(1):20. PubMed ID: 36641445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.